Vaccine Scheduler

Influenza: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Months		Years
	6	23	2	3	5	6	7	8	11	12	17	18	45	50	55	59	60	64	≥ 65
Austria	IIV3/LAIV											IIV3					aIIV3 / IIV3-HD ¹

Belgium	IIV4²																		aIIV/QIV-HD³

Bulgaria	IIV3/LAIV⁴											IIV3/IIV4⁵							IIV3/IIV4⁶

Croatia	IIV3⁷																		IIV3

Cyprus	IIV4⁸																		aIIV4

Czechia	IIV3/LAIV⁹													IIV3/TIV-HD¹⁰

Denmark												IIV¹¹							IIV3¹²

Estonia	IIV4¹³																IIV4

Finland	IIV4/LAIV¹⁴																		IIV4

France			IIV4																IIV4

Germany	IIV4¹⁵																IIV4/QIV-HD¹⁶

Greece	IIV3¹⁷																IIV4/aIIV4/QIV-HD¹⁸

Hungary	IIV4¹⁹																IIV3

Iceland	IIV3/LAIV²⁰									IIV3²⁰							IIV3²⁰

Ireland	IIV4/LAIV²¹																IIV4²²

Italy	LAIV/IIV3/cIIV3²³																aIIV3/TIV-HD/IIV3²³

Latvia	IIV4/LAIV		IIV4/LAIV²⁴														QIV-HD

Liechtenstein	IIV4²⁵												IIV4²⁶

Lithuania	IIV3²⁷		IIV3²⁷					IIV3²⁷											IIV3²⁷

Luxembourg																			IIV4

Malta	IIV4²⁸														IIV4²⁸

Netherlands	IIV²⁹																IIV4

Norway												IIV3/aIIV3³⁰							IIV3/aIIV3³⁰

Poland	IIV4												IIV4/QIV-HD³¹

Portugal	IIV4³²		IIV4³²														IIV4/QIV-HD³²

Romania	IIV3/IIV4/LAIV												IIV3/IIV4/QIV-HD³³

Slovakia	IIV4/LAIV³⁴															IIV4

Slovenia	IIV4³⁵																		IIV4

Spain	IIV4/cIIV4/LAIV																IIV4/aIIV4/cIIV4/QIV-HD

Sweden	IIV4/LAIV																		IIV4

Footnotes:

For all >60 years old, aIIV3 (funded) and IIV3-HD (not funded) is recommended. More information: https://impfen.gv.at/impfungen/influenza or https://www.sozialministerium.gv.at/impfplan (p. 54ff)
For HCWs (paid by employer), pregnant women and people with comorbidities (partially reimbursed).
Partially funded. For persons 65-74y without comorbidities, only aIIV is partially reimbursed. In part of the country (Flanders), the vaccine is provided and administered entirely free of charge for residents of nursing homes.
Inactivated vaccines are recommended for children over 6 months of age. LAIV is recommended for children over 24 months of age. Vaccines are not funded but vaccine administration is funded by the national health insurance.
Inactivated vaccines are recommended for all people over 18 years of age. Vaccines are not funded but vaccine administration is funded by the national health insurance only for insured
For people over 65 years of age influenza and pneumococcal vaccines and administration are free of charge and funded according to the National programme.
Children and adolescents that are not at risk can get the influenza vaccine from six months old but it is not funded. Vaccination is recommended and funded by Croatian Health Insurance for all children at risk.
The vaccine can be given as a specific recommendation for individuals six months to 17 years old with a chronic medical condition. https://www.gov.cy/moh/en/national-vaccination-advisory-committee/
Universal recommendation is given for all age groups but children from six months to five years old belong to the high-risk group. For more information: https://vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-chripce-4
For all individuals 65 years old and older is funded from the National Health System
Vaccination during pregnancy. See https://www.ssi.dk/vaccinationer/vaccination-af-gravide
In children, there is no general recommendation, only for certain risk groups. More information: https://www.ssi.dk/vaccinationer/influenzavaccination
Vaccination is free for the following groups: residents of welfare institutions, people aged 60 years and older, children aged six months to seven years old, pregnant women, children and adolescents 7–17 years old who have an increased risk of becoming seriously ill due to their health condition (heart and blood vessel diseases, oncological diseases, immunodeficiency, diabetes and obstructive lung disease).
more information: https://thl.fi/en/topics/infectious-diseases-and-vaccinations/information-about-vaccinations/vaccination-programme-for-children-and-adults
Children/adolescence between the age of 6 month and 17 years with one or more medical condition or underlying disease, are recommended to receive seasonal influenza vaccination. Medical conditions or underlying diseases to consider are: -Chronic diseases of the respiratory tract, including asthma and chronic obstructive pulmonary disease (COPD) -Chronic cardiovascular, liver and kidney disease -Diabetes mellitus and other metabolic diseases -Chronic neurological diseases, e. g., multiple sclerosis with relapses triggered by infections -Congenital or acquired immunodeficiency -HIV infection More information is available at: https://www.rki.de/DE/Aktuelles/Publikationen/Epidemiologisches-Bulletin/2024/04_24.pdf?__blob=publicationFile&v=4
For more information: https://www.rki.de/EN/Topics/Infectious-diseases/Immunisation/STIKO/STIKO-recommendations/recommendations_content.html
Since 2024 flu vaccination is recommended to all children between 6 months -5 years of age. In addition, Greece has recommendations for children and adolescents belonging to high-risk groups. Source: https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/emboliasmoi/ethniko-programma-emboliasmwn-epe-paidiwn-kai-efhbwn
QIV-HD and aIIV4 recommended in adults aged =65 years.
Hungary’s recommendation is for children 6–35 months old with chronic pulmonary, cardiovascular, renal or hepatic disease, metabolic disorders or immunosuppression due to disease or treatment
Annual vaccination (IIV3 to be re-introduced in 2026 with LAIV-3 for 2-4 year olds from 2026) - funded recommendation.
LAIV is recommended and funded for 24 months to <18 years. IIV4 was also recommended and funded for children aged >6 months to 17 years with medical conditions in 2024-25 influenza season.
The national influenza programme was funded for those aged 60 years in 2024-25 influenza season. Influenza vaccine was also recommended for those aged 50-59 but not funded for vaccine and its administration.
Vaccination is offered free of charge to all children from six months to six years old and adults aged 60 years old and older. From seven yo to 59 years of age, vaccination is offered free of charge to all people with chronic medical conditions.
The vaccine is recommended for children and adolescents aged 24 months to 17 years with chronic lung or cardiovascular diseases, chronic metabolic or kidney conditions or immunodeficiency, as well as those receiving immunosuppressive therapy or long-term acetylsalicylic acid therapy. https://www.spkc.gov.lv/lv/vakcinacija#valsts-apmaksata-vakcinacija-pret-gripu
For 6 months to 8 years, vaccination is not recommended for healthy children but is recommended for premature babies (born before gestational week 33 (e.g. <32 weeks and seven days of pregnancy) or with a birth weight of less than 1 500g) from the age of six months and for the first two winters after birth. For 6 months to 18 years, vaccination is recommended for children and adolescents with chronic medical conditions.
For individuals aged >=18 years, the recommended influenza vaccines are Vaxigrip Tetra®, Fluarix Tetra®, Influvac Tetra®, and Flucelvax Tetra®. The same vaccines (Vaxigrip Tetra®, Fluarix Tetra®, Influvac Tetra®, Flucelvax Tetra®) are also recommended for those aged >=50, >=55, >=59, and >=60 years. For individuals aged >=65 years, the recommended vaccine is Efluelda®.
Vaccination is recommended for children 2 to 7 years old, for persons 65 years of age and older and risk groups persons (with underlying conditions, pregnant women, health care workers, medical students).
Recommended for this age group, but available for free to everyone aged 6 months and older.
Indicated to individuals in medical high risk groups of 6 months of age and older and in pregnant women. More information available at: https://lci.rivm.nl/factsheets/influenzavaccinatie
https://www.fhi.no/en/va/vaccines-for-adults/vaccines-in-the-adult-immunisation-programme/vaccines-in-the-adult-immunisation-programme/the-influenza-vaccine---information-for-the-public/
The vaccine and its administration are partially funded (50%). QIV-HD in adults aged 60 years and above. https://szczepienia.pzh.gov.pl/szczepionki/grypa/?strona=9#jak-refundowane-sa-szczepionki-przeciw-grypie-w-sezonie-2024/2025
Recommended to children from 6 to 23 months of age and individuals in medical high-risk groups from 2 to 59 years of age. QIV-HD is funded for people aged 85 years and older. More information is available at: https://www.dgs.pt/ficheiros-de-upload-2013/25-gripe-sazonal-ultima-atualizacao-28112025-pdf.aspx
For adults aged 45–65 years without chronic medical conditions, the influenza vaccines are 50% reimbursed. For those aged 65 years and above the vaccine is fully reimbursed.
Vaccination against influenza is supported by the legislation for children 6 months – 12 years, individuals with specified chronic medical conditions, older adults aged 59 years and above and people accommodated in long-term facilities. However, the vaccination is generally recommended and fully funded to the whole population in every influenza season.
Vaccination is also recommended for the specific risk groups (children aged 6–23 months, pregnant women, those with chronic medical conditions, older adults aged 65 years and above).